ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

CompletedOBSERVATIONAL

Enrollment

759

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions

Immunocompromised HostCritical Care

Trial Locations (7)

Chu Amiens Picardie, Amiens

Ch Bethune, Béthune

Grand Hopital de L'Est Francilien, Jossigny

CH LENS, Lens

Hôpital Roger Salengro, CHU, Lille

Hospices Civils de Lyon, Lyon

C.H de Roubaix, Roubaix

All Listed Sponsors

lead

University Hospital, Lille

OTHER

NCT04043793 - ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients | Biotech Hunter | Biotech Hunter